Amol Deshpande serves as Managing Director, Head of Direct Investments, and as a member of the staff investment committee. Prior to joining TMRS, he served as a Managing Director and management committee member of Redesign Health, where he made investments with a mission to accelerate healthcare innovation.
He previously held roles at Soros Fund Management, Luminus Management and JLL Partners, where he invested in private and public businesses across multiple sectors, including healthcare, industrials and technology. Deshpande began his career advising leading technology companies on M&A and capital markets activities at Morgan Stanley in Menlo Park, CA, and received his B.A. with concentrations in applied mathematics, economics and finance from Northwestern University.